I presume the Deputy is referring to the recent announcement by the HSE that it is suspending certain products from the List of Reimbursable Items. The products in question have been identified both nationally and internationally as not being cost effective or being of lesser benefit to patients.
In the current financial environment the Health Service Executive (HSE) is facing a challenge to deliver services in a way that will minimise any adverse impact on patients and continue to protect, as far as possible, the most vulnerable citizens.